MedTrace Logo

Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema

NCT06787885 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-02-06

No results posted yet for this study

Summary

To evaluate the impact of using different antibiotic regimens including single and combined agents as the empirical therapy and evaluate the clinical outcomes regarding safety, efficacy, and pharmacodynamics parameters.

Conditions

  • Empyema, Pleural

Interventions

DRUG

Levofloxacin + clindamycin

Group 1

DRUG

Levofloxacin + cefipime

Group 2

DRUG

Moxifloxacin + meronam

Group 3

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Principal Investigators

  • Raghda Roshdy Hussein, Assistant professor · Faculty of pharmacy Beni suef University

  • Marwa Kamal Tolba, Assistant professor · Faculty of pharmacy Fayoum University

  • Yassmin Mohamed Medany, Lecturer · Faculty of pharmacy Benisuef University

  • Mona Ibrahim Ahmed, Assistant professor · Faculty of Medicine Fayoum University

  • Abdelrahman Ahmed Mohamed, Teaching assistant · Faculty of pharmacy Fayoum University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-04-01
Completion
2025-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06787885 on ClinicalTrials.gov